Learn more

IDM IMMUNO DESIGNED MOLECULES

Overview
  • Total Patents
    118
About

IDM IMMUNO DESIGNED MOLECULES has a total of 118 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are FIGENE LLC, SAECHSISCHES SERUMWERK and EPITOGENESIS INC.

Patent filings in countries

World map showing IDM IMMUNO DESIGNED MOLECULESs patent filings in countries

Patent filings per year

Chart showing IDM IMMUNO DESIGNED MOLECULESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bartholeyns Jacques 68
#2 Romet-Lemonne Jean-Loup 34
#3 Chokri Mohamed 32
#4 Monsigny Michel 21
#5 Midoux Patrick 16
#6 Fouron Yves 13
#7 Nardin Alessandra 11
#8 Abastado Jean-Pierre 11
#9 Erbacher Patrick 6
#10 Roche-Degremont Annie-Claude 6

Latest patents

Publication Filing date Title
EP1909758A1 Process for the preparation of liposomal formulations
EP1747994A1 Serially linked containers for containing a sterile solution
CA2508720A1 Method to measure a t cell response and its uses to qualify antigen-presenting cells
AU2003254363A1 Compositions containing macrophages and uses thereof
AU2003233978A1 Rapid generation of activated mononuclear antigen presenting cells from monocytes
EP1430076A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
EP1409648A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
US7252996B2 Ancillary composition for the preparation of committed mature dentritic cells
AU2955202A Dehydrated antigen presenting cells usable for vaccination
US6881413B1 Humanized biomaterials, a process for their preparation and their applications
AU5530100A New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
EP1150694A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method
EP1135481A1 New oligomeric conjugates liable to transfer biological molecules into cells
EP1103602A1 New lymphocytes, a process for preparing the same and their use, in therapeutics
US6821516B1 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
AU3601499A Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
WO9953027A1 Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency
WO9953026A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
WO9950391A1 Stimulated monocyte derived cells, their preparation and uses